In its latest move to expand pharmaceutical retail presence, Alibaba’s health unit Alibaba Health Information Technology Ltd., has announced to make a total investment of RMB862 million (US$121 million) in a pharmaceutical retail chain in Guizhou. Alibaba Health has agreed to purchase 14.54% shares of Guizhou Ensure Chain Pharmacy Company Ltd., for RMB421,758,850 (US$61.6 million). It also agreed to contribute additional RMB404,321,529 (US$59 million) to increase the later’s capital. Alibaba Health will hold 25% of the company eventually, according to …

Alibaba Health Invests $121M In Chinese Pharmaceutical Retail Chain Business appeared first on China Money Network.